Irenic Capital Management LP (hereinafter “Irenic”, “we”, “us”, “our” or the “Firm” or the
“Investment Manager”) was organized in October 2021 as a Delaware limited partnership
with a principal place of business in New York, New York.
Adam Katz, the Chief Investment Officer (“CIO”), and Andrew Dodge, the Director of Research
(“Director of Research”), are the majority beneficial owners of the Firm.
We are an affiliate of Irenic Capital Evergreen Fund GP LLC , Irenic Capital Opportunity Fund GP
LLC, Irenic Adelaide GP LLC, and Irenic Capital Panther GP LLC (the “General Partners”, each a
“General Partner”).
We serve as the investment adviser, with discretionary trading authority, to private, pooled
investment vehicles, the securities of which are offered through a private placement
memorandum to accredited investors, as defined under the Securities Act of 1933, as
amended, and qualified purchasers, as defined under the Investment Company Act of 1940,
as amended. We do not tailor our advisory services to the individual needs of any particular
investor.
Irenic manages the following private, pooled investment vehicles:
• Irenic Capital Evergreen Cayman Fund Ltd., a Cayman Islands exempted company;
• Irenic Capital Evergreen US Fund LP, a Delaware limited
partnership;
• Irenic Capital Evergreen Master Fund LP, a Cayman Islands exempted limited
partnership;
• Irenic Capital Opportunity Cayman Fund LP, a Cayman Islands exempted limited
partnership;
• Irenic Capital Opportunity US Fund LP, a Delaware limited partnership;
• Irenic Capital Opportunity Master Fund LP, a Cayman Islands exempted limited
partnership;
• Irenic Capital Panther Aggregator Master Fund LP, a Delaware limited partnership;
• Irenic Capital Panther Aggregator Feeder Fund LP, a Delaware limited partnership;
• Irenic Schooner LLC, a Delaware limited liability company; and
• Irenic Adelaide SPV LP, a Delaware limited partnership, each referred to as a “Fund”
or “Client”, and collectively referred to as the “Funds” or the “Clients”.
The Funds’ “Limited Partners” or “Shareholders” are hereafter collectively referred to as the
“Investors” where appropriate.
Our investment decisions and advice with respect to the Funds are subject to each Fund’s
investment objectives and guidelines, as set forth in its respective “Offering Documents.”
We do not currently participate in any Wrap Fee Programs.
As of December 31, 2023, Irenic managed approximately $1,039,277,043 regulatory assets
under management on a discretionary basis.